Search…

    Saved Articles

    You have not yet added any article to your bookmarks.

    Browse

    GDPR Compliance

    We use cookies to ensure you get the best experience on our website. By continuing to use our site, you accept our use of cookies, Privacy Policy, and Terms of Service.

    Imitation weight-loss drugs boosted Hims & Hers. Executives cashed in.

    6 hours ago

    Hims & Hers launched a pharmacy-made weight-loss drug last year, taking advantage of an FDA rule allowing it to temporarily make copies of Novo Nordisk’s semaglutide. The gambit boosted the telehealth firm’s stock price, and executives made millions selling shares.
    Click here to Read more
    Prev Article
    Fan critically injured in fall from 21-foot wall at Pirates game
    Next Article
    Elektrik santrallerine 1,89 milyar liralık kapasite mekanizması desteği

    Related Business Updates:

    Comments (0)

      Leave a Comment